Delivery Order SPE2DB22D2211-SPE2DB25FSDDD
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $36,330.77 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of use on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $7,266.59. This competitively awarded, firm fixed-price delivery order is set to conclude by August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition based on...
- The Defense Logistics Agency awarded a delivery order valued at $8,427.06 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under a firm fixed price contract type. This non-set-aside award was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for the DLA and is a major pharmaceutical distributor specializing in medical supply chain support for federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $19,065.20 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units. This non-competitive, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,492.00 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewables under contract 4568864711. This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Emverm 100 mg tablet chewables, with a ceiling value of $32,123.06. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was competitively awarded to the...
- The Defense Logistics Agency awarded a delivery order valued at $65,417.77 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable unit dose supplies. This firm fixed-price delivery order, issued on August 19, 2025, represents a non-competitive set-aside contract with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide EMVERM 100 MG TABLET CHEW UDS pharmaceutical products. The $21,387.17 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract awarded by DLA to AmerisourceBergen Drug Corp valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of EMVERM 100 MG TABLET CHEW UDS. The order, valued at $33,296.99, is a firm fixed-price contract with an ultimate completion date of August 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a...